NAVANAPHAR fundamentals
An in-depth look to NAVANA PHARMACEUTICALS LTD operating, investing, and financing activities
NAVANAPHAR free cash flow for Q2 25 is 414.51 M BDT. For 2024, NAVANAPHAR free cash flow was -1.1 B BDT and operating cash flow was 233.32 M BDT.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
−1.00 B
−500.00 M
0.00
500.00 M
1.00 B
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: BDT
Q1 '23
Sep 2022
Q2 '23
Dec 2022
Q3 '23
Mar 2023
Q4 '23
Jun 2023
Q1 '24
Sep 2023
Q2 '24
Dec 2023
Q3 '24
Mar 2024
Q4 '24
Jun 2024
Q1 '25
Sep 2024
Q2 '25
Dec 2024
TTM
Cash from operating activitiesYoY growth
140.43 M
—
−28.31 M
—
61.69 M
+62.36%
−138.37 M
−24.12%
−58.60 M
−141.73%
368.60 M
—
32.48 M
−47.35%
307.69 M
—
650.17 M
Cash from investing activitiesYoY growth
−254.07 M
—
−486.80 M
—
−193.26 M
+40.22%
−236.32 M
+55.94%
4.36 M
—
−892.23 M
−83.29%
−228.64 M
−18.31%
144.37 M
—
−972.14 M
Cash from financing activitiesYoY growth
−64.32 M
—
484.79 M
—
48.30 M
−90.47%
332.29 M
−67.07%
67.83 M
—
462.54 M
−4.59%
197.24 M
+308.33%
−442.24 M
−233.09%
285.37 M
Free cash flowYoY growth
−124.30 M
—
−515.11 M
—
−90.88 M
+82.42%
−427.18 M
−5.97%
−57.77 M
+53.53%
−523.26 M
−1.58%
−184.02 M
−102.50%
414.51 M
—
−350.54 M